Skip to content
2000
Volume 10, Issue 3
  • ISSN: 1570-1611
  • E-ISSN: 1875-6212

Abstract

Current evidence suggests that chronic kidney disease (CKD) is associated with an excess risk for cardiovascular disease (CVD) events. In patients with stage 3 CKD (estimated glomerular filtration rate-eGFR 30-59 ml/min/1.73m2) lifestyle measures and appropriate drugs may reduce CVD risk and stabilize (or even reverse) renal function deterioration. Furthermore, CKD is included in recent international guidelines as a population at high CVD risk. The aim should be to effectively reduce CVD risk as well as progression of CKD.

Loading

Article metrics loading...

/content/journals/cvp/10.2174/157016112799959422
2012-05-01
2025-05-23
Loading full text...

Full text loading...

/content/journals/cvp/10.2174/157016112799959422
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test